Cargando…

CCNG1 (Cyclin G1) regulation by mutant‐P53 via induction of Notch3 expression promotes high‐grade serous ovarian cancer (HGSOC) tumorigenesis and progression

TP53 mutation is considerably common in advanced high‐grade serous ovarian cancer (HGSOC) and significantly associated with a poor prognosis. In this study, we investigated the role of Cyclin G1 (CCNG1), a target gene of wild‐type TP53 (P53wt), in HGSOC and the possible regulatory mechanism between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Ying, Zhang, Qing, Miao, Chunying, Dongol, Samina, Li, Yinuo, Jin, Chenjuan, Dong, Ruifeng, Li, Yingwei, Yang, Xingsheng, Kong, Beihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346265/ https://www.ncbi.nlm.nih.gov/pubmed/30565428 http://dx.doi.org/10.1002/cam4.1812

Ejemplares similares

MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC
por: Sun, Chenggong, et al.
Publicado: (2020)

Differential expression of cyclins CCNB1 and CCNG1 is involved in the chondrocyte damage of kashin-beck disease
por: Setiwalidi, Kaidiriye, et al.
Publicado: (2022)

FAM225A promotes sorafenib resistance in hepatocarcinoma cells through modulating miR-130a-5p–CCNG1 interaction network
por: Liu, Yan-Tong, et al.
Publicado: (2020)

Differential DNA methylation in high-grade serous ovarian cancer (HGSOC) is associated with tumor behavior
por: Reyes, Henry D., et al.
Publicado: (2019)

IQGAP3 promotes cancer proliferation and metastasis in high-grade serous ovarian cancer
por: Dongol, Samina, et al.
Publicado: (2020)

Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS)
por: Garziera, Marica, et al.
Publicado: (2018)

Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis
por: Peignon, Grégory, et al.
Publicado: (2011)

Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC)
por: Garziera, Marica, et al.
Publicado: (2019)

MicroRNA-27a functions as an oncogene in human osteosarcoma by targeting CCNG1
por: Lin, Tao, et al.
Publicado: (2018)

Exploiting Oncogenic Drivers along the CCNG1 Pathway for Cancer Therapy and Gene Therapy
por: Al-Shihabi, Ahmad, et al.
Publicado: (2018)

miR-23b suppresses lung carcinoma cell proliferation through CCNG1
por: Han, Hongsheng, et al.
Publicado: (2018)

miR-23b suppresses lung carcinoma cell proliferation through CCNG1
por: Han, Hongsheng, et al.
Publicado: (2019)

Estrogen Receptor-Beta2 (ERβ2)–Mutant p53–FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC)
por: Oturkar, Chetan C., et al.
Publicado: (2022)

Validation analysis of the novel imaging-based prognostic radiomic signature in patients undergoing primary surgery for advanced high-grade serous ovarian cancer (HGSOC)
por: Fotopoulou, Christina, et al.
Publicado: (2021)

Cancer Stem Cell Markers—Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian Cancer (HGSOC) Based on The Cancer Genome Atlas Analysis
por: Iżycka, Natalia, et al.
Publicado: (2023)

MiR-4269 suppresses the tumorigenesis and development of pancreatic cancer by targeting ZEB1/OTX1 pathway
por: Sui, Xin, et al.
Publicado: (2020)

Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity
por: Liu, Baohui, et al.
Publicado: (2015)

lncRNA MSC-AS1 Aggravates Diabetic Nephropathy by Regulating the miR-325/CCNG1 Axis
por: Zhao, Hongtu, et al.
Publicado: (2022)

PD-L1 regulates tumorigenesis and autophagy of ovarian cancer by activating mTORC signaling
por: Gao, Hongmin, et al.
Publicado: (2019)

3D dynamic cultures of HGSOC organoids to model innovative and standard therapies
por: Cavarzerani, Enrico, et al.
Publicado: (2023)

Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy
por: Shen, Jiliang, et al.
Publicado: (2016)

Retracted: lncRNA MSC-AS1 Aggravates Diabetic Nephropathy by Regulating the miR-325/CCNG1 Axis
por: Healthcare Engineering, Journal of
Publicado: (2023)

Long non-coding RNA ROR1-AS1 induces tumorigenesis of colorectal cancer by affecting Wnt/β-catenin signaling pathway
por: Wang, Wei, et al.
Publicado: (2019)

PGC‐1α inhibits polyamine metabolism in Cyclin E1‐driven ovarian cancer
por: Guo, Ting, et al.
Publicado: (2019)

YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress
por: Qu, Si‐Yao, et al.
Publicado: (2017)

miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma
por: Dong, Ruifen, et al.
Publicado: (2014)

Up-regulation of miR-34c-5p inhibits nasopharyngeal carcinoma cells by mediating NOTCH1
por: Xu, Xin, et al.
Publicado: (2020)

Model Cell Lines and Tissues of Different HGSOC Subtypes Differ in Local Estrogen Biosynthesis
por: Pavlič, Renata, et al.
Publicado: (2022)

Progesterone prevents HGSOC by promoting precancerous cell pyroptosis via inducing fibroblast paracrine
por: Wu, Nayiyuan, et al.
Publicado: (2023)

Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes
por: Cunnea, Paula, et al.
Publicado: (2023)

The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer
por: Shang, Yulong, et al.
Publicado: (2015)

Isoliquiritigenin inhibits the proliferation, migration and metastasis of Hep3B cells via suppressing cyclin D1 and PI3K/AKT pathway
por: Huang, Yun, et al.
Publicado: (2020)

Epigenetically altered miR-193b targets cyclin D1 in prostate cancer
por: Kaukoniemi, Kirsi M, et al.
Publicado: (2015)

p21/Cyclin E pathway modulates anticlastogenic function of Bmi-1 in cancer cells
por: Deng, Wen, et al.
Publicado: (2015)

RAD51D Secondary Mutation-Mediated Resistance to PARP-Inhibitor-Based Therapy in HGSOC
por: Xu, Jing, et al.
Publicado: (2023)

MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer
por: Hasegawa, S, et al.
Publicado: (2014)

CCNG2 Overexpression Mediated by AKT Inhibits Tumor Cell Proliferation in Human Astrocytoma Cells
por: Zhang, Danfeng, et al.
Publicado: (2018)

miR-1246 Targets CCNG2 to Enhance Cancer Stemness and Chemoresistance in Oral Carcinomas
por: Lin, Shih-Shen, et al.
Publicado: (2018)

Notch signaling in serous ovarian cancer
por: Groeneweg, Jolijn W, et al.
Publicado: (2014)

MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma
por: Dai, Chen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r0is97d92gd53keja5g3uth132